Company: REVB
Filing Date: 2025-05-29
Form Type: PRE 14A
Source: 0000950170-25-078948
Chunk: 60

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-29
Form: PRE 14A
Chunk 60
---
 served during the last fiscal year, as a member of the compensation committee or other board committee performing equivalent functions of any other entity that has one or more executive officers serving as one of Revelation’s directors or on the Compensation Committee.

Code of Conduct and Ethics

The Revelation Board adopted a Code of Ethics that applies to all its employees including its principal executive and financial officers.

<div align='center'>46</div>

Family Relationships There are no family relationships among our directors or executive officers. Involvement in Certain Legal Proceedings None of our directors, executive officers, promoters or control persons has been involved in any events requiring disclosure under Item 401(f) of Regulation S-K. Attendance of Directors at Board Meetings and Annual Meeting of Stockholders During 2024, the Board of Directors met six times, the Compensation Committee met one time, the Nominating and Corporate Governance Committee met one and the Audit Committee met four times. Each director who was on the Board during this timeframe attended at least 100% of the aggregate number of meetings held during his or her term of service. In 2024, the Company held its Annual Meeting of Stockholders which was attended by Mr. Rolke. The Company does not have a policy requiring its directors to attend the Annual Meeting of Stockholders. Director Compensation The general policy of the Board is that compensation for independent directors should be a fair mix between cash and equity-based compensation. Additionally, the Company reimburses directors for reasonable expenses incurred during the course of their performance. There are no long-term incentive or medical reimbursement plans. The Company does not pay directors who are part of management for Board service in addition to their regular employee compensation. The Board determines the amount of director compensation. The Board may delegate such authority to the compensation committee. The following table sets forth the total cash and equity compensation paid to our non-employee directors for service on our board of directors during 2024:

| Name                            |     | Fees earned or 
   paid in cash 
            ($) |     | Option-based 
 awards       
 ($)(5)       |     |  Total 
    ($) |
| George Tidmarsh, M.D., Ph.D.(1) |     |         60,000 |     | -            |     | 60,000 |
| Jennifer Carver, BSN, MBA       |     |         60,000 |     | -            |     | 60,000 |
| Jess Roper                      |     |         60,000 |     | -            |     | 60